Next Generation Antibody Therapeutics Market Industry, Size, Development and Demand Forecast to 2020

GLOBAL INDUSTRY INSIGHT: Global Next-Generation Antibody Therapeutics Market Size, Share, Development, Growth and Demand Forecast to

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

The global next generation antibody therapeutics market was worth $ 1,328.3 million in 2014, and it is expected to grow at a CAGR of 44% during 2015-2020. Next-generation antibody therapeutics market is escalating with high growth rate due to growing prevalence of chronic diseases. Some of the major reasons leading to increase in number of chronic disease cases include unhealthy lifestyle, poor diet, and addictions, such as smoking, and others. In addition, various pharmaceutical and biotechnology companies are collaborating with other companies and organizations for R&D of next-generation antibody therapeutics which further drives the market of nextgeneration antibody therapeutics.

Explore Report Description with Detailed TOC on “Global Next-Generation Antibody Therapeutics Market” at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market The next-generation antibody therapeutics industry has made huge growth in the recent years. The growing healthcare expenditure has increased the overall research and development investment by various organizations.

This leads to the growth of global next-generation antibody therapeutics market. The Autoimmune/Inflammatory market is growing at an average annual growth rate of over 46.4%. The Fc Engineered Antibodies market on the other hand grew at a CAGR of 56.8% during 2015-2020.

The restraints associated with next-generation antibody therapeutics market include high cost, stringent regulatory requirements and time consuming approval process of drugs.

A significant capital investment is

required for the research and manufacturing of next-generation therapeutics. The manufacturing process of nextgeneration antibody therapeutics is very complex, as it requires specialized equipment and careful handling techniques. Next-generation antibody therapeutics is a biologic product, and thus requires specific downstream process for their production. This leads to the high cost of manufacturing next-generation antibody therapeutics.

Different countries have distinct regulatory requirements for launching a product in the market. Strict regulatory requirements and extended approval time hinders the market for next-generation antibody therapeutics.

The key companies operating in the global next-generation antibody therapeutics market include F. Hoffmann-La Roche Ltd, Seattle Genetics Inc., Pfizer Inc., ImmunoGen Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Xencor Inc., Bristol-Myers Squibb Company, AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG. TABLE OF CONTNET Chapter 1. Research Scope & Methodology 1.1 Market Definition 1.2 Market Scope

© P&S Market Research. All rights reserved

2

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

1.2.1 Global next-generation antibody therapeutics market breakdown by therapeutic area 1.2.2 Global next-generation antibody therapeutics market breakdown by technology 1.2.3 Global next-generation antibody therapeutics market breakdown by geography 1.3 Research Methodology and Sources Explore Report Description with Detailed ToC on “Global Next-Generation Antibody Therapeutics Market” at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market Chapter 2. Executive Summary 2.1 Key Findings 2.2 Research Summary Chapter 3. Market Outlook 3.1 Introduction 3.2 Trends in the Next-generation Antibody Therapeutics Market 3.2.1 Increasing popularity of antibody-drug conjugate (ADC) technology 3.2.2 Increasing number of collaborations for R&D of next-generation antibody therapeutics 3.3 Factors Driving the Market and its Impact on Market Forecast 3.3.1 Growing prevalence of chronic diseases 3.3.2 Increasing R&D for improved products 3.3.3 Increasing healthcare expenditure 3.3.4 Technological progressions in antibody therapeutics 3.3.5 Impact analysis of drivers on market forecast 3.4 Factors Hindering the Market and its Impact on Market Forecast 3.4.1 High cost of next-generation antibody therapeutics 3.4.2 Stringent regulatory requirements and time-consuming approval process for new drugs 3.4.3 Impact analysis of restraints on market forecast

© P&S Market Research. All rights reserved

3

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

Browse Related Research at: https://www.psmarketresearch.com/industry-report/healthcare Chapter 4. Next-Generation Antibody Therapeutics Drug Pipeline Analysis 4.1 Next-Generation Antibody Therapeutics Under Development Chapter 5. Global Market Size and Forecast (2014 – 2020) 5.1 Global Next-Generation Antibody Therapeutics Market Breakdown by Therapeutic Area 5.2 Global Next-Generation Antibody Therapeutics Market Breakdown by Technology 5.3 Global Next-Generation Antibody Therapeutics Market Breakdown by Region Chapter 6. Next-Generation Antibody Therapeutics Market Breakdown by Therapeutic Area 6.1 Oncology Next-Generation Antibody Therapeutics Market 6.2 Autoimmune/Inflammatory Next-Generation Antibody Therapeutics Market Chapter 7. Next-Generation Antibody Therapeutics Market Breakdown by Technology 7.1 Antibody-Drug Conjugates (ADCs) Market 7.2 Bispecific Antibodies Market 7.3 Fc-engineered Antibodies Market 7.4 Antibody Fragments and Antibody-like Proteins Market 7.5 Biosimilar Antibody Products Market Chapter 8. Next-Generation Antibody Therapeutics Market Breakdown by Geography 8.1 North America Next-Generation Antibody Therapeutics Market 8.1.1 North America next-generation antibody therapeutics market breakdown by country 8.1.2 North America next-generation antibody therapeutics market breakdown by therapeutic area 8.1.3 North America next-generation antibody therapeutics market breakdown by technology 8.2 Europe Next-Generation Antibody Therapeutics Market 8.2.1 Europe next-generation antibody therapeutics market breakdown by country 8.2.2 Europe next-generation antibody therapeutics market breakdown by therapeutic area

© P&S Market Research. All rights reserved

4

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

8.2.3 Europe next-generation antibody therapeutics market breakdown by technology 8.3 Asia-Pacific Next-Generation Antibody Therapeutics Market 8.3.1 Asia-Pacific next-generation antibody therapeutics market breakdown by country 8.3.2 Asia-Pacific next-generation antibody therapeutics market breakdown by therapeutic area 8.3.3 Asia-Pacific next-generation antibody therapeutics market breakdown by technology 8.4 Rest of the World Next-Generation Antibody Therapeutics Market 8.4.1 Rest of the World next-generation antibody therapeutics market breakdown by therapeutic area 8.4.2 Rest of the World next-generation antibody therapeutics market breakdown by technology Browse Related Research at: https://www.psmarketresearch.com/industry-report/healthcare Chapter 9. Competitive Positioning and Market Share Analysis 9.1 Porter's Five Forces of Competitive Position Analysis 9.1.1 Bargaining power of buyers 9.1.2 Bargaining power of suppliers 9.1.3 Threat of new entrants 9.1.4 Intensity of rivalry 9.1.5 Threat of substitutes 9.2 Global Next-Generation Antibody Therapeutics Market Share, By Company 9.3 Competitive Positioning of Key Players in the Next-Generation Antibody Therapeutics Market Explore Report Description with Detailed ToC on “Global Next-Generation Antibody Therapeutics Market” at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market Chapter 10. Company Profiles 10.1 Key Company Profiles 10.1.1 F. Hoffmann-La Roche Ltd.

© P&S Market Research. All rights reserved

5

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

10.1.1.1 Business overview 10.1.1.2 Product and service offerings 10.1.2 Kyowa Hakko Kirin Co. Ltd. 10.1.2.1 Business overview 10.1.2.2 Product and service offerings 10.1.3 Seattle Genetics Inc. 10.1.3.1 Business overview 10.1.3.2 Product and service offerings 10.1.4 ImmunoGen Inc. 10.1.4.1 Business overview 10.1.4.2 Product and service offerings 10.1.5 Bristol-Myers Squibb Company 10.1.5.1 Business overview 10.1.5.2 Product and service offerings 10.1.6 Pfizer Inc. 10.1.6.1 Business overview 10.1.6.2 Product and service offerings 10.1.7 Amgen Inc. 10.1.7.1 Business overview 10.1.7.2 Product and service offerings 10.1.8 Biogen 10.1.8.1 Business overview 10.1.8.2 Product and service offerings 10.1.9 Bayer AG

Š P&S Market Research. All rights reserved

6

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

10.1.9.1 Business overview 10.1.9.2 Product and service offerings 10.1.10 Xencor Inc. 10.1.10.1 Business overview 10.1.10.2 Product and service offerings 10.1.11 Takeda Pharmaceuticals Company Limited 10.1.11.1 Business overview 10.1.11.2 Product and service offerings 10.1.12 AstraZeneca PLC 10.1.12.1 Business overview 10.1.12.2 Product and service offerings 10.1.13 Dyax Corp.

10.1.13.1 Business overview 10.1.13.2 Product and service offerings 10.2 Strategic Developments in the Next-Generation Antibody Therapeutics Market 10.2.1 Mergers & acquisitions 10.2.2 Collaborations and partnerships 10.2.3 Product launches/ approval Browse Related Research at: https://www.psmarketresearch.com/industry-report/healthcare Chapter 11. Appendix 11.1 List of Abbreviations Explore Report Description with Detailed ToC on “Global Next-Generation Antibody Therapeutics Market” at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market LIST OF TABLES

© P&S Market Research. All rights reserved

7

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION TABLE 2 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SNAPSHOT (2014, 2015, AND 2020) TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS TABLE 4 ESTIMATED AVERAGE TIMELINE FOR CLINICAL TRIAL APPROVAL IN VARIOUS COUNTRIES TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS TABLE 6 MAJOR NEXT-GENERATION ANTIBODY THERAPEUTICS DRUG PIPELINE TABLE 7 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY THERAPEUTIC AREA, $M (2014 – 2020) TABLE 8 LOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY TECHNOLOGY, $M (2014 – 2020) TABLE 9 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 10 GLOBAL ONCOLOGY NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN

BY REGION, $M (2014 – 2020) TABLE 11 GLOBAL AUTOIMMUNE/INFLAMMATORY NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 12 GLOBAL ANTIBODY DRUG CONJUGATES MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 13 GLOBAL BISPECIFIC ANTIBODIES MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 14 GLOBAL FC ENGINEERED ANTIBODIES MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 15 GLOBAL ANTIBODY FRAGMENTS AND ANTIBODY-LIKE PROTEINS MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 16 GLOBAL BIOSIMILARS ANTIBODY PRODUCTS MARKET BREAKDOWN BY REGION, $M (2014 – 2020) TABLE 17 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY COUNTRY, $M (2014 – 2020) TABLE 18 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY THERAPEUTIC AREA $M (2014 – 2020) TABLE 19 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY TECHNOLOGY, $M (2014 – 2020)

© P&S Market Research. All rights reserved

8

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

TABLE 20 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY COUNTRY, $M (2014 – 2020) TABLE 21 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY THERAPEUTIC AREA $M (2014 – 2020) TABLE 22 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY TECHNOLOGY, $M (2014 – 2020) TABLE 23 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY COUNTRY, $M (2014 – 2020) TABLE 24 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY THERAPEUTIC AREA, $M (2014 – 2020) TABLE 25 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY TECHNOLOGY, $M (2014 – 2020) TABLE 26 REST OF THE WORLD NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN

BY THERAPEUTIC AREA, $M (2014 – 2020) TABLE 27 REST OF THE WORLD NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN

BY TECHNOLOGY, $M (2014 – 2020) TABLE 28 F. HOFFMANN-LA ROCHE LTD – KEY FACTS TABLE 29 KYOWA HAKKO KIRIN CO. LTD. – KEY FACTS TABLE 30 SEATTLE GENETICS INC. – KEY FACTS TABLE 31 IMMUNOGEN INC. – KEY FACTS TABLE 32 BRISTOL-MYERS SQUIBB COMPANY – KEY FACTS TABLE 33 PFIZER INC.– KEY FACTS TABLE 34 AMGEN INC. – KEY FACTS TABLE 35 BIOGEN – KEY FACTS TABLE 36 BAYER AG – KEY FACTS TABLE 37 XENCOR, INC. – KEY FACTS TABLE 38 TAKEDA PHAXRMACEUTICALS COMPANY LIMITED. – KEY FACTS TABLE 39 ASTRAZENECA PLC. – KEY FACTS

© P&S Market Research. All rights reserved

9

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

TABLE 40 DYAX CORP. – KEY FACTS Browse Related Research at: https://www.psmarketresearch.com/industry-report/healthcare LIST OF FIGURES FIG 1 RESEARCH SCOPE FOR GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET FIG 2 RESEARCH METHODOLOGY FOR GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET FIG 3 HEALTH EXPENDITURE AS PERCENTAGE OF GDP (2002 AND 2012) FIG 4 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, $M (2014 – 2020) FIG 5 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY THERAPEUTIC AREA (2014 AND 2020) FIG 6 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY TECHNOLOGY $M (2014 – 2020) FIG 7 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY TECHNOLOGY (2014 AND 2020) FIG 8 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY REGION, $M (2014 – 2020) FIG 9 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY REGION (2014 AND 2020) FIG 10 GLOBAL ONCOLOGY NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY REGION, $M (2014 - 2020) FIG 11 GLOBAL ONCOLOGY NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY REGION (2014 AND 2020) FIG 12 GLOBAL AUTOIMMUNE/INFLAMMATORY NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY REGION, $M (2014 – 2020) FIG 13 GLOBAL AUTOIMMUNE/INFLAMMATORY NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY REGION (2014 AND 2020) FIG 14 GLOBAL ANTIBODY DRUG CONJUGATES MARKET SIZE BY REGION, $M (2014 – 2020) FIG 15 GLOBAL ANTIBODY DRUG CONJUGATES MARKET SHARE, BY REGION (2014 AND 2020) FIG 16 GLOBAL BISPECIFIC ANTIBODIES MARKET SIZE BY REGION, $M (2014-2020)

© P&S Market Research. All rights reserved

10

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

FIG 17 GLOBAL BISPECIFIC ANTIBODIES MARKET SHARE, BY REGION (2014 AND 2020) FIG 18 GLOBAL FC ENGINEERED ANTIBODIES MARKET SIZE BY REGION, $M (2014 – 2020) FIG 19 GLOBAL FC ENGINEERED ANTIBODIES MARKET SHARE, BY REGION (2014 AND 2020) FIG 20 GLOBAL ANTIBODY FRAGMENTS AND ANTIBODY-LIKE PROTEINS MARKET SIZE BY REGION, $M (2014 - 2020) FIG 21 GLOBAL ANTIBODY FRAGMENTS AND ANTIBODY-LIKE PROTEINS MARKET SHARE, BY REGION (2014 AND 2020) FIG 22 GLOBAL BIOSIMILARS ANTIBODY PRODUCTS MARKET SIZE BY REGION, $M (2014 – 2020) FIG 23 GLOBAL BIOSIMILARS ANTIBODY PRODUCTS MARKET SHARE, BY REGION (2014 AND 2020) FIG 24 GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET, BY GEOGRAPHY (2020) FIG 25 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY COUNTRY, $M (2014 – 2020) FIG 26 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY COUNTRY (2014 AND 2020) FIG 27 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA $M (2014 – 2020) FIG 28 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY THERAPEUTIC AREA (2014 AND 2020) FIG 29 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY TECHNOLOGY $M (2014 – 2020) FIG 30 NORTH AMERICA NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY TECHNOLOGY (2014 AND 2020) FIG 31 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY COUNTRY, $M (20142020) FIG 32 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY COUNTRY (2014 AND 2020) FIG 33 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA $M (2014 – 2020) FIG 34 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY THERAPEUTIC AREA (2014 AND 2020)

© P&S Market Research. All rights reserved

11

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

FIG 35 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE, BY TECHNOLOGY $M (2014 – 2020) FIG 36 EUROPE NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY TECHNOLOGY (2014 AND 2020) FIG 37 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY COUNTRY, $M (2014-2020) FIG 38 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY COUNTRY (2014 AND 2020) FIG 39 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY THERAPEUTIC AREA, $M (2014 – 2020) FIG 40 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY THERAPEUTIC AREA (2014 AND 2020) FIG 41 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY TECHNOLOGY, $M (2014 – 2020) FIG 42 ASIA-PACIFIC NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SHARE, BY TECHNOLOGY (2014 AND 2020) FIG 43 REST OF THE WORLD NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY THERAPEUTIC AREA, $M (2014 – 2020) FIG 44 REST OF THE WORLD NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY TECHNOLOGY, $M (2014 – 2020) FIG 45 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS FIG 46 MARKET SHARE OF KEY PLAYERS IN THE GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET (2014) FIG 47 COMPETITIVE POSITIONING OF KEY PLAYERS IN THE GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET (2014) Browse Related Research at: https://www.psmarketresearch.com/industry-report/healthcare

© P&S Market Research. All rights reserved

12

Global Next-Generation Antibody Therapeutics Market (Size of $1,328 million in 2014) to Witness 44% CAGR during 2015 – 2020

About P&S Market Research P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact: Deep Assistant – Client Partner 347, 5th Ave. #1402 New York City, NY - 10016 Toll-free: +1-888-778-7886 (USA/Canada) Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com

© P&S Market Research. All rights reserved

13